CISA’s Nick Andersen told reporters that he didn’t know of a completion timeline, but talks were ongoing across government ...

Intel has announced adjustments to the construction timeline for its semiconductor manufacturing facilities in New Albany. Naga Chandrasekaran, executive vice president and chief global operations ...

Due to the delays in activating new clinical sites, Talphera now anticipates study completion in the first half of 2026, moving back from its previous expectation of year-end 2025. The company is ...

— Company now expects to complete enrollment of 150 patients in Q2 2026, with a Phase 3 data readout in mid-2027; Rolling NDA submission planned to initiate in first half 2027— — Discussions with FDA ...

Stoke Therapeutics Announces Updates to Timelines for the Completion of Enrollment and a Phase 3 Data Readout from the EMPEROR Study of Zorevunersen for the Treatment of Dravet Syndrome — Company now ...